Lars Jørgen Østergaard

Co-administered with a Combined Hepatitis A and B Vaccine (HepA/B) is Immunogenic and Well Tolerated in Subjects Aged 11-17 Years

Research output: Contribution to conferencePosterResearchpeer-review

  • The Department of Infectious Diseases
Original languageEnglish
Publication year2010
Publication statusPublished - 2010

See relations at Aarhus University Citationformats

Activities

ID: 34134525